Evidence map›Paper›PMID 36100671›Full record

ArticleNature2022

Author Correction: Sestrin mediates detection of and adaptation to low-leucine diets in Drosophila.

Xin Gu, Patrick Jouandin, Pranav V Lalgudi, Rich Binari, Max L Valenstein, Michael A Reid, Annamarie E Allen, Nolan Kamitaki, Jason W Locasale, Norbert Perrimon and 1 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. A viral Cyclin D homolog protein hijacks the metabolic stress sensor SESN2 to promote primary effusion lymphoma growth.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Xin Gu *Whitehead Institute for Biomedical Research, Cambridge, MA, USA. xingu@mit.edu.ORCID http://orcid.org/0000-0002-3393-6927
Patrick Jouandin *Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. Patrick_Jouandin@hms.harvard.edu.ORCID http://orcid.org/0000-0002-8656-7694
Pranav V LalgudiWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Rich BinariDepartment of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Max L ValensteinWhitehead Institute for Biomedical Research, Cambridge, MA, USA.
Michael A ReidDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA.ORCID http://orcid.org/0000-0001-6222-9538
Annamarie E AllenDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA.
Nolan KamitakiDepartment of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0614-0189
Jason W LocasaleDepartment of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, USA.ORCID http://orcid.org/0000-0002-7766-3502
Norbert PerrimonDepartment of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. perrimon@genetics.med.harvard.edu.ORCID http://orcid.org/0000-0001-7542-472X
David M Sabatini

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36100671

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.